Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-May-13 2:01 PM View:  | Sabatino Thomas J Jr Director | Unigene Laboratories Inc. (UGNE) | 01-May-13 | Grant | 10,000 | -- | -- | 5% 215.78K to 225.78K | |
| 03-May-13 2:01 PM View: | Tune Joel A. Director | Unigene Laboratories Inc. (UGNE) | 01-May-13 | Grant | 10,000 | -- | -- | 4% 253.8K to 263.8K | |
| 03-May-13 2:01 PM View: | Odlaug Theron Edwin Director | Unigene Laboratories Inc. (UGNE) | 01-May-13 | Grant | 10,000 | -- | -- | 6% 174.37K to 184.37K | |
| 03-May-13 1:59 PM View: | Wyszomierski Jack L Director | Unigene Laboratories Inc. (UGNE) | 01-May-13 | Grant | 10,000 | -- | -- | 6% 154.83K to 164.83K | |
| 04-Jan-13 2:40 PM View: | Odlaug Theron Edwin Director | Unigene Laboratories Inc. (UGNE) | 03-Jan-13 | Grant | 92,308 | $0.13 | $12,000.00 | 112% 82.06K to 174.37K | (52%) |
| 04-Jan-13 2:40 PM View: | Wyszomierski Jack L Director | Unigene Laboratories Inc. (UGNE) | 03-Jan-13 | Grant | 107,692 | $0.13 | $14,000.00 | 228% 47.14K to 154.83K | (52%) |
| 04-Jan-13 2:40 PM View: | Sabatino Thomas J Jr Director | Unigene Laboratories Inc. (UGNE) | 03-Jan-13 | Grant | 69,231 | $0.13 | $9,000.03 | 47% 146.55K to 215.78K | (52%) |
| 04-Jan-13 2:40 PM View: | Tune Joel A. Director | Unigene Laboratories Inc. (UGNE) | 03-Jan-13 | Grant | 123,077 | $0.13 | $16,000.00 | 94% 130.72K to 253.8K | (52%) |
| 18-Jul-12 9:54 PM View: | Victory Park Capital Adviso... Director 10% Owner | Unigene Laboratories Inc. (UGNE) | 16-Jul-12 | Disposition (other) | 9,147,460 | -- | -- | (50%) 18.29M to 9.15M | |
| 18-Jul-12 9:54 PM View: | Victory Park Capital Adviso... Director 10% Owner | Unigene Laboratories Inc. (UGNE) | 16-Jul-12 | Acquisition (other) | 9,147,460 | -- | -- | 100% 9.15M to 18.29M | |
| 10-Jul-12 4:09 PM View: | Sabatino Thomas J Jr Director | Unigene Laboratories Inc. (UGNE) | 06-Jul-12 | Grant | 30,303 | $0.30 | $8,999.99 | 26% 116.25K to 146.55K | (82%) |
| 10-Jul-12 4:10 PM View: | Tune Joel A. Director | Unigene Laboratories Inc. (UGNE) | 06-Jul-12 | Grant | 53,872 | $0.30 | $16,000.00 | 70% 76.85K to 130.72K | (82%) |
| 10-Jul-12 4:09 PM View: | Odlaug Theron Edwin Director | Unigene Laboratories Inc. (UGNE) | 06-Jul-12 | Grant | 40,404 | $0.30 | $12,000.00 | 97% 41.66K to 82.06K | (82%) |
| 10-Jul-12 4:10 PM View: | Wyszomierski Jack L Director | Unigene Laboratories Inc. (UGNE) | 06-Jul-12 | Grant | 47,138 | $0.30 | $14,000.00 | 100% 0 to 47.14K | (82%) |
| 03-May-12 4:16 PM View: | Tune Joel A. Director | Unigene Laboratories Inc. (UGNE) | 01-May-12 | Grant | 10,000 | -- | -- | 15% 66.85K to 76.85K | |
| 03-May-12 4:17 PM View: | Odlaug Theron Edwin Director | Unigene Laboratories Inc. (UGNE) | 01-May-12 | Grant | 10,000 | -- | -- | 32% 31.66K to 41.66K | |
| 09-Jan-12 5:16 PM View: | Odlaug Theron Edwin Director | Unigene Laboratories Inc. (UGNE) | 05-Jan-12 | Grant | 21,661 | $0.55 | $12,000.20 | 217% 10.0K to 31.66K | (90%) |
| 09-Jan-12 5:17 PM View: | Sabatino Thomas J Jr Director | Unigene Laboratories Inc. (UGNE) | 05-Jan-12 | Grant | 16,245 | $0.55 | $8,999.73 | 16% 100.0K to 116.25K | (90%) |
| 09-Jan-12 5:17 PM View: | Tune Joel A. Director | Unigene Laboratories Inc. (UGNE) | 05-Jan-12 | Grant | 21,661 | $0.55 | $12,000.20 | 48% 45.19K to 66.85K | (90%) |
| 09-Jan-12 5:16 PM View: | Zvi Eiref Director | Unigene Laboratories Inc. (UGNE) | 05-Jan-12 | Grant | 25,271 | $0.55 | $14,000.10 | 13% 187.42K to 212.69K | (90%) |
| 22-Dec-11 4:46 PM View: | Mehta Nozer VP, Biological R&D | Unigene Laboratories Inc. (UGNE) | 21-Dec-11 | Market Purchase | 1,400 | $0.54 | $749.00 | < 1% 201.5K to 202.9K | (90%) |
| 22-Dec-11 4:48 PM View: | Sabatino Thomas J Jr Director | Unigene Laboratories Inc. (UGNE) | 21-Dec-11 | Market Purchase | 100,000 | $0.63 | $62,880.00 | 100% 0 to 100.0K | (91%) |
| 22-Dec-11 4:49 PM View: | Tavakkol Roxanne VP, Global Regulatory Affairs | Unigene Laboratories Inc. (UGNE) | 21-Dec-11 | Market Purchase | 1,500 | $0.63 | $952.50 | 100% 0 to 1.5K | (91%) |
| 22-Dec-11 4:49 PM View: | Palmer Ashleigh President & CEO Director | Unigene Laboratories Inc. (UGNE) | 21-Dec-11 | Market Purchase | 10,000 | $0.53 | $5,287.50 | 20% 50.0K to 60.0K | (89%) |
| 22-Dec-11 4:48 PM View: | Tune Joel A. Director | Unigene Laboratories Inc. (UGNE) | 21-Dec-11 | Market Purchase | 15,000 | $0.56 | $8,475.00 | 50% 30.19K to 45.19K | (90%) |
| 22-Dec-11 4:49 PM View: | Advanced Life Sciences Hold... Director | Unigene Laboratories Inc. (UGNE) | 21-Dec-11 | Market Purchase | 10,000 | $0.53 | $5,300.00 | 100% 0 to 10.0K | (89%) |
| 22-Dec-11 4:46 PM View: | Zvi Eiref Director | Unigene Laboratories Inc. (UGNE) | 21-Dec-11 | Market Purchase | 10,000 | $0.53 | $5,275.00 | 6% 177.42K to 187.42K | (89%) |
| 05-Jan-12 7:32 PM View: | Odlaug Theron Edwin Director | Unigene Laboratories Inc. (UGNE) | 21-Dec-11 | Market Purchase | 10,000 | $0.53 | $5,300.00 | 100% 0 to 10.0K | (89%) |
| 22-Dec-11 4:46 PM View: | Mayes, Gregory T. VP, Corp Development and GC | Unigene Laboratories Inc. (UGNE) | 21-Dec-11 | Market Purchase | 2,000 | $0.52 | $1,050.00 | 100% 0 to 2.0K | (89%) |
| 22-Dec-11 4:50 PM View: | Shields Paul Vice Pres. Mfg. Operations | Unigene Laboratories Inc. (UGNE) | 21-Dec-11 | Market Purchase | 2,000 | $0.52 | $1,050.00 | 18% 11.1K to 13.1K | (89%) |
| 22-Dec-11 4:48 PM View: | Thomas Jenene D. VP of Investor Relations | Unigene Laboratories Inc. (UGNE) | 21-Dec-11 | Market Purchase | 2,000 | $0.52 | $1,050.00 | 100% 0 to 2.0K | (89%) |
| 08-Jul-11 5:07 PM View: | Tune Joel A. Director | Unigene Laboratories Inc. (UGNE) | 06-Jul-11 | Grant | 8,654 | $1.04 | $9,000.16 | 40% 21.54K to 30.19K | (95%) |
| 08-Jul-11 5:04 PM View: | Miller Marvin Director | Unigene Laboratories Inc. (UGNE) | 06-Jul-11 | Grant | 11,538 | $1.04 | $11,999.50 | 10% 113.47K to 125.01K | (95%) |
| 08-Jul-11 5:03 PM View: | Zvi Eiref Director | Unigene Laboratories Inc. (UGNE) | 06-Jul-11 | Grant | 11,538 | $1.04 | $11,999.50 | 7% 165.89K to 177.42K | (95%) |
| 08-Jul-11 5:03 PM View: | Bloom Allen Director | Unigene Laboratories Inc. (UGNE) | 06-Jul-11 | Grant | 17,308 | $1.04 | $18,000.30 | 5% 314.71K to 332.01K | (95%) |
| 21-Jun-11 4:51 PM View: | Bloom Allen Director | Unigene Laboratories Inc. (UGNE) | 20-Jun-11 | Option Exercise | 10,000 | $0.66 | $6,600.00 | 3% 304.71K to 314.71K | |
| 15-Jun-11 4:17 PM View: | Mehta Nozer Vice Pres. Biological R&D | Unigene Laboratories Inc. (UGNE) | 14-Jun-11 | Option Exercise | 75,000 | $0.31 | $22,875.00 | 59% 126.5K to 201.5K | |
| 03-May-11 5:09 PM View: | Tune Joel A. Director | Unigene Laboratories Inc. (UGNE) | 01-May-11 | Grant | 10,000 | -- | -- | 87% 11.54K to 21.54K | |
| 03-May-11 5:10 PM View: | Miller Marvin Director | Unigene Laboratories Inc. (UGNE) | 01-May-11 | Grant | 10,000 | -- | -- | 10% 103.47K to 113.47K | |
| 03-May-11 5:09 PM View: | Zvi Eiref Director | Unigene Laboratories Inc. (UGNE) | 01-May-11 | Grant | 10,000 | -- | -- | 6% 155.89K to 165.89K | |
| 03-May-11 5:08 PM View: | Bloom Allen Director | Unigene Laboratories Inc. (UGNE) | 01-May-11 | Grant | 10,000 | -- | -- | 3% 294.71K to 304.71K | |
| 07-Jan-11 4:30 PM View: | Bloom Allen Director | Unigene Laboratories Inc. (UGNE) | 05-Jan-11 | Grant | 23,077 | $0.78 | $18,000.10 | 8% 271.63K to 294.71K | (93%) |
| 07-Jan-11 4:30 PM View: | Tune Joel A. Director | Unigene Laboratories Inc. (UGNE) | 05-Jan-11 | Grant | 11,538 | $0.78 | $8,999.64 | 100% 0 to 11.54K | (93%) |
| 07-Jan-11 4:30 PM View: | Miller Marvin Director | Unigene Laboratories Inc. (UGNE) | 05-Jan-11 | Grant | 15,385 | $0.78 | $12,000.30 | 17% 88.09K to 103.47K | (93%) |
| 07-Jan-11 4:30 PM View: | Zvi Eiref Director | Unigene Laboratories Inc. (UGNE) | 05-Jan-11 | Grant | 15,385 | $0.78 | $12,000.30 | 11% 140.5K to 155.89K | (93%) |
| 22-Dec-10 6:45 PM View: | Levy Richard N Director 10% Owner | Unigene Laboratories Inc. (UGNE) | 22-Dec-10 | Market Purchase | 50,000 | $0.74 | $37,000.00 | < 1% 9.1M to 9.15M | (93%) |
| 22-Dec-10 9:55 AM View: | Zvi Eiref Director | Unigene Laboratories Inc. (UGNE) | 21-Dec-10 | Market Purchase | 5,000 | $0.72 | $3,600.00 | 4% 135.5K to 140.5K | (92%) |
| 22-Dec-10 6:45 PM View: | Levy Richard N Director | Unigene Laboratories Inc. (UGNE) | 21-Dec-10 | Market Purchase | 50,000 | $0.75 | $37,500.00 | < 1% 9.05M to 9.1M | (93%) |
| 22-Dec-10 9:55 AM View: | Zvi Eiref Director | Unigene Laboratories Inc. (UGNE) | 20-Dec-10 | Market Purchase | 10,000 | $0.73 | $7,300.00 | 8% 125.5K to 135.5K | (92%) |
| 22-Dec-10 6:45 PM View: | Levy Richard N Director | Unigene Laboratories Inc. (UGNE) | 20-Dec-10 | Market Purchase | 50,000 | $0.75 | $37,500.00 | < 1% 9.0M to 9.05M | (93%) |
